1.06187
Meglumine
EMPROVE® EXPERT, Ph. Eur., ChP, JP, USP
Pharma Manufacturing
Synonym(s):
N-Methyl-D-glucamine, 1-Deoxy-1-methylaminosorbitol, 1-Deoxy-1-methylaminosorbitol, 1-Deoxy-1-(methylamino)-D-glucitol, Meglumine
About This Item
Recommended Products
Agency
ChP
JP
Ph. Eur.
USP
Quality Level
product line
EMPROVE® EXPERT
form
solid
autoignition temp.
~662 °F
pH
11 (20 °C, 10 g/L in H2O)
bp
210 °C/1013 hPa
mp
129-131.5 °C (lit.)
application(s)
liquid formulation
pharmaceutical
solid formulation
solubility enhancement
storage temp.
no temp limit
SMILES string
CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
InChI
1S/C7H17NO5/c1-8-2-4(10)6(12)7(13)5(11)3-9/h4-13H,2-3H2,1H3/t4-,5+,6+,7+/m0/s1
InChI key
MBBZMMPHUWSWHV-BDVNFPICSA-N
Looking for similar products? Visit Product Comparison Guide
General description
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
Application
Features and Benefits
- Solubility and bioavailability enhancement of APIs
- Excellent counterion performance, a viable alternative to sodium
- API grade: manufactured under the cGMP ICH Q7 guideline for APIs
- Sole manufacturing location for API-grade meglumine in Europe
- Multi-compendial product, complying with all major pharmacopeias, including ChP
- Meglumine Emprove® API has also been successfully co-reviewed in China
Legal Information
Application
also commonly purchased with this product
related product
Storage Class Code
11 - Combustible Solids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
This overview describes the challenges when developing parenteral formulations and strategies to overcome them and reduce the risk of production.
This overview describes the challenges when developing parenteral formulations and strategies to overcome them and reduce the risk of production.
This overview describes the challenges when developing parenteral formulations and strategies to overcome them and reduce the risk of production.
This overview describes the challenges when developing parenteral formulations and strategies to overcome them and reduce the risk of production.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service